| Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. | glioblastoma, |
| Data suggest that both KLF5 (Kruppel like factor 5) and FYN (FYN proto-oncogene) are important in regulation of migration in bladder cancer cells; KLF5 up-regulates cell migration, lamellipodia formation, FYN expression, and FAK phosphorylation. | bladder, |
| Data show that fyn proto-oncogene protein (FYN) expression is deregulated in acute myeloid leukemia and that higher expression of FYN, in combination with FLT3 protein-ITD mutation, resulted in enrichment of the STAT5 transcription factor signaling. | leukemia, |
| A role for the fyn oncogene in metastasis of methylcholanthrene-induced fibrosarcoma A cells. | fibrosarcoma, |
| The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation. | None |
| In vivo phosphorylation and membrane association of the fyn proto-oncogene product in IM-9 human lymphoblasts. | None |
| Cell type and developmental regulation of the fyn proto-oncogene in neural retina. | None |
| Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein. | None |
| Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. | None |
| Regional location of a novel yes-related proto-oncogene, syn, on human chromosome 6 at band q21. | None |